1. Academic Validation
  2. ASP1 (BACE2) cleaves the amyloid precursor protein at the beta-secretase site

ASP1 (BACE2) cleaves the amyloid precursor protein at the beta-secretase site

  • Mol Cell Neurosci. 2000 Nov;16(5):609-19. doi: 10.1006/mcne.2000.0884.
I Hussain 1 D J Powell D R Howlett G A Chapman L Gilmour P R Murdock D G Tew T D Meek C Chapman K Schneider S J Ratcliffe D Tattersall T T Testa C Southan D M Ryan D L Simmons F S Walsh C Dingwall G Christie
Affiliations

Affiliation

  • 1 Department of Neuroscience Research, SmithKline Beecham Pharmaceuticals, New Frontiers Science Park, Harlow. Essex, United Kingdom.
Abstract

Sequential proteolytic processing of the Amyloid Precursor Protein (APP) by beta- and gamma-secretases generates the 4-kDa amyloid (A beta) peptide, a key component of the amyloid plaques seen in Alzheimer's disease (AD). We and Others have recently reported the identification and characterisation of an aspartic proteinase, Asp2 (BACE), as Beta-secretase. Here we describe the characterization of a second highly related aspartic proteinase, Asp1 as a second Beta-secretase candidate. Asp1 is expressed in brain as detected at the mRNA level and at the protein level. Transient expression of Asp1 in APP-expressing cells results in an increase in the level of beta-secretase-derived soluble APP and the corresponding carboxy-terminal fragment. Paradoxically there is a decrease in the level of soluble A beta secreted from the cells. Asp1 colocalizes with APP in the Golgi/endoplasmic reticulum compartments of cultured cells. Asp1, when expressed as an Fc fusion protein (Asp1-Fc), has the N-terminal sequence ALEP..., indicating that it has lost the prodomain. Asp1-Fc exhibits Beta-secretase activity by cleaving both wild-type and Swedish variant (KM/NL) APP Peptides at the Beta-secretase site.

Figures